Linike Medical Group Ltd. (LNMG)
0.0255
-0.01
(-27.14%)
USD |
OTCM |
Mar 16, 16:00
Linike Medical Group EPS Diluted (Quarterly) : 0.0004 for Jan. 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 1.030 |
| Accuray, Inc. | -0.1138 |
| Alphatec Holdings, Inc. | -0.1428 |
| Boston Scientific Corp. | 0.4493 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.2429M |
| Revenue (Quarterly) | 2.421M |
| Total Expenses (Quarterly) | 2.178M |
| Enterprise Value | 16.78M |
| Gross Profit Margin (Quarterly) | 92.32% |
| Profit Margin (Quarterly) | 10.03% |
| Earnings Yield | 13.73% |
| Operating Earnings Yield | 13.75% |
| Normalized Earnings Yield | 13.73 |